Radiopharm Theranostics: Rad202 Shows Positive Tumor Uptake & Biodistribution
Radiopharm Theranostics presented data at EMIM 2025 demonstrating the effectiveness of RAD202, a HER2-targeting single domain antibody, for both...
eClinical Tech News
Curevo Raises $110M for Shingles Vaccine
Curevo Vaccine secured $110 million in Series B funding to advance the development of its shingles vaccine, amezosvatein. The...
Exopten Shows Promise in Spinal Cord Injury Recovery
NurExone Biologic Inc. has successfully completed a preclinical study of its ExoPTEN treatment for spinal cord injuries, demonstrating significant...
KRRO-110 FDA Orphan Drug Designation for A1AD Deficiency
Korro Bio announced that its investigational medicine, KRRO-110, received orphan drug designation from the FDA for treating Alpha-1 Antitrypsin...
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
Eton Pharmaceuticals announced positive results from a bioequivalence study of ET-600, its patented oral solution of desmopressin for central...
FDA Approves Expanded Label for Iluvien®
ANI Pharmaceuticals received FDA approval for an expanded label for ILUVIEN, adding chronic non-infectious uveitis affecting the posterior segment...
EnnoDC Presents Positive Phase I AMV Data at CROI 2025
EnnoDC’s Phase I ANRS VRI06 trial demonstrated that its Antibody Mediated Vaccine (AMV) technology induces a safe, durable, and...
BioAdaptives Zeranovia Weight Loss Dosage Trial Shows Promise
BioAdaptives, Inc. (OTC: BDPT) has completed dosage trials for its weight loss product, Zeranovia™, showing significant weight loss (5-7...
Atyr Pharma Publishes Efzofitimod Data in Prestigious Journal
aTyr Pharma announced a publication in Science Translational Medicine detailing the mechanism of action of efzofitimod, its lead therapeutic...
ACTG CMV Study Shows Improved Aging in HIV/CMV Patients
The AIDS Clinical Trials Group (ACTG) presented promising phase 2 trial results at the 2025 Conference on Retroviruses and...